Where does Edwards Lifesciences CardiAQ LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Edwards Lifesciences CardiAQ LLC ranks #3,428 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Edwards Lifesciences CardiAQ LLC hold?

Edwards Lifesciences CardiAQ LLC holds 108 US utility patents granted between 2016 and 2025, spanning 6 technology areas.

What is Edwards Lifesciences CardiAQ LLC's Innovation Score?

Edwards Lifesciences CardiAQ LLC has an Innovation Score of 40.1 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Edwards Lifesciences CardiAQ LLC's patent grant rate increasing or decreasing?

Edwards Lifesciences CardiAQ LLC's recent grant velocity is -9% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Edwards Lifesciences CardiAQ LLC's patents?

Edwards Lifesciences CardiAQ LLC's patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Edwards Lifesciences CardiAQ LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Edwards Lifesciences CardiAQ LLC

Q: What technology areas does Edwards Lifesciences CardiAQ LLC focus on?

Edwards Lifesciences CardiAQ LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 103 patents, ranking #48 of 3,082 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 108 granted patents across 6 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Edwards ranks #3,428 of 49,997 tracked US assignees by granted-patent volume, with 108 patents across 6 technology areas.

#3,428
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.1/100): 17.7
avg claims per patent: -9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3428 · US Corporation #3,428 · 108 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MID 108 grants
TOP-DECILE #3,428/49,997
PHOTO-FINISH Böllhoff Verbindungs…
CPC-NARROW A61F · 6 areas
INNOV-PAR 40.1/100
CLAIMS-RICH 17.7 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Böllhoff Verbindungstechnik GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Edwards’s 40.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.2 pts (40%) Velocity 4.6 pts (11%) Breadth 8.7 pts (22%) Claim depth 10.6 pts (26%)

Qualcomm Incorporated · highest

85
Evalve · near

40
RaySearch Laboratori… · near

40
Brand & KG · near

40
Edwards Lifesciences… · this assignee

40
JMJ Korea · near

40
3D Lighting… · lowest

7

What this shows Edwards's Innovation Score is 40.1/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Edwards?

Each dot is one of Edwards’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Edwards’s own 17.7 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Edwards vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Edwards's grants concentrate

Edwards Lifesciences CardiAQ LLC is a focused PatentsView assignee: 6 CPC subclasses with 95.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (16 grants) versus a trough of 7 in 2023. By volume, Edwards sits between Böllhoff Verbindungstechnik GmbH and GE OIL & GAS UK Ltd.

Edwards's three-year grant acceleration

From 2019–2021 to 2022–2024, Edwards Lifesciences CardiAQ LLC moved from 36 to 25 grants (0.69x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,174. See the growth leaderboard.

Böllhoff Verbindu…

108
Celgard

108
DJO

108
Ecosense Lighting

108
Essential Products

108
Framatome

108
Formlabs

108
GE OIL & GAS UK

108
Edwards Lifescien… ◀

108

What this shows Edwards holds 108 patents at rank #3,428, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Edwards

By rank, the assignees closest to #3,428 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Edwards's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Edwards, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Edwards ranks #48 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

JMJ Korea Co., Ltd. 40 Brand GMBH & Co KG 40 Evalve, Inc. 40 RaySearch Laboratories AB 40

Similar claim depth

Nearest assignees by average claims per patent (17.7 here).

Spine Wave, Inc. 17.7 avg Tornier 17.7 avg KHS GmbH 17.7 avg Glaxosmithkline Biologicals SA 17.7 avg

Edwards's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Edwards Lifesciences CardiAQ LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	13	12.0%
2017	16	14.8%
2018	11	10.2%
2019	13	12.0%
2020	13	12.0%
2021	10	9.3%
2022	10	9.3%
2023	7	6.5%
2024	8	7.4%
2025partial year	7	6.5%

Which technologies does Edwards Lifesciences CardiAQ LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 103

Y10T - Technical Subjects Covered BY Former US Classification 13

A61B - DIAGNOSIS; SURGERY; Identification 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Edwards Lifesciences CardiAQ LLC's patent record in context - here's where to go next.

Edwards Lifesciences CardiAQ LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 95.4% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #3,428 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Edwards Lifesciences CardiAQ LLC against Böllhoff Verbindungstechnik GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.